Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis.

Zhang, Meng; Liu, Yi; Chen, Jing; Chen, Lei; Zhang, Li; Chen, Xianguo; Hao, Zongyao; Liang, Chaozhao

Zhang, Meng; Liu, Yi; Chen, Jing; Chen, Lei; Zhang, Li; Chen, Xianguo; Hao, Zongyao; Liang, Chaozhao.

Afiliación

Zhang M; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, People's Republic of China.
Liu Y; Institute of Urology, Anhui Medical University, Hefei, 230022, Anhui, People's Republic of China.
Chen J; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, 230022, Anhui, People's Republic of China.
Chen L; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, People's Republic of China.
Zhang L; Institute of Urology, Anhui Medical University, Hefei, 230022, Anhui, People's Republic of China.
Chen X; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, 230022, Anhui, People's Republic of China.
Hao Z; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, People's Republic of China.
Liang C; Institute of Urology, Anhui Medical University, Hefei, 230022, Anhui, People's Republic of China.

J Inflamm Res ; 15: 2551-2566, 2022.

Article en En | MEDLINE | ID: mdl-35479835

Palabras clave

AMD3100; CXCL12/CXCR4; chronic nonbacterial prostatitis; mRNA array sequencing

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Inflamm Res Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google